Cochrane Abstracts
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Subcutaneous Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439472/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism.
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439472/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism. Accessed January 13, 2025.
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439472/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism
Subcutaneous Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439472/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
ID - 439472
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439472/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
